US Investors Flock to Healthcare Dividend Stocks Amid Rising Bankruptcy Filings

As US bankruptcy filings surge by 12% year over year and recession warnings intensify in 2026, investors seek steadier ground. The rising credit stress and narrow AI-driven market create both risk and opportunity. To navigate this environment, three dividend-focused stocks are examined: Abbott Laboratories (ABT), Elevance Health (ELV), and UnitedHealth Group (UNH). These companies offer a mix of recurring income, diversified healthcare portfolios, and potential for margin recovery.

Abbott Laboratories is a global healthcare company with a market cap of around $191 billion. It generates revenue from medical devices ($22.5B), diagnostics products ($10B), nutritional products ($8.3B), and pharmaceuticals ($5.8B). The company has a long dividend history, but margins have come under pressure recently.

Elevance Health is a large US health benefits company with a market cap of around $84.6 billion. It collects recurring premiums across commercial, Medicare, Medicaid, and specialty plans, then layers on pharmacy and care management services through its Carelon units. The company has a 2% dividend yield and is leaning into data-driven care and AI-backed cost control.

UnitedHealth Group is a large healthcare company with a market cap of around $355 billion. It combines traditional insurance with the Optum services platform, generating revenue from UnitedHealthcare ($346.5B), Optum Rx ($155.2B), Optum Health ($100B), and Optum Insight ($19.7B). The company has a 2.36% dividend yield and is working to improve margins through technology and value-based care programs.

These stocks offer a mix of income, diversification, and potential for margin recovery in a challenging market environment. However, investors should be aware of the risks associated with each company, including pressure from changing Medicare member profiles, high-cost specialty drugs, and regulatory scrutiny.